Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411176 | SCV000485656 | likely pathogenic | Bardet-Biedl syndrome 1 | 2016-01-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002523851 | SCV003026165 | pathogenic | Bardet-Biedl syndrome | 2022-02-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys285*) in the BBS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BBS1 are known to be pathogenic (PMID: 12118255). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 370358). This variant has not been reported in the literature in individuals affected with BBS1-related conditions. |